Trupanion (NASDAQ:TRUP) Shares Gap Up on Analyst Upgrade

Trupanion, Inc. (NASDAQ:TRUP)’s stock price gapped up prior to trading on Friday after Bank of America raised their price target on the stock from $47.00 to $56.00. The stock had previously closed at $42.00, but opened at $43.12. Bank of America currently has a buy rating on the stock. Trupanion shares last traded at $43.88, with a volume of 104,413 shares changing hands.

Other research analysts also recently issued research reports about the company. William Blair assumed coverage on Trupanion in a report on Friday, July 19th. They issued an “outperform” rating for the company. Northland Securities raised their price target on shares of Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research report on Thursday. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Stifel Nicolaus reissued a “hold” rating and set a $30.00 price objective (up from $22.00) on shares of Trupanion in a report on Friday, August 9th. Finally, Piper Sandler boosted their target price on shares of Trupanion from $30.00 to $38.00 and gave the stock a “neutral” rating in a research report on Friday, August 9th. Four analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $39.00.

Insider Transactions at Trupanion

In related news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,764 shares of company stock worth $405,238. 5.50% of the stock is currently owned by insiders.

Institutional Trading of Trupanion

Large investors have recently modified their holdings of the company. ProShare Advisors LLC grew its position in Trupanion by 33.8% in the 1st quarter. ProShare Advisors LLC now owns 121,417 shares of the financial services provider’s stock worth $3,352,000 after purchasing an additional 30,645 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in Trupanion in the 1st quarter worth approximately $473,000. 8 Knots Management LLC acquired a new stake in Trupanion in the 4th quarter valued at approximately $21,165,000. Seven Eight Capital LP acquired a new position in Trupanion during the 4th quarter worth $1,399,000. Finally, Quest Partners LLC acquired a new position in Trupanion during the 4th quarter worth $67,000.

Trupanion Stock Performance

The company has a market cap of $1.80 billion, a P/E ratio of -66.88 and a beta of 1.74. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The company has a 50 day moving average price of $40.56 and a 200-day moving average price of $31.70.

Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04. The firm had revenue of $314.80 million for the quarter, compared to analysts’ expectations of $309.33 million. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. Trupanion’s quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.33) EPS. Equities analysts expect that Trupanion, Inc. will post -0.37 EPS for the current fiscal year.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.